跳至主要内容
临床试验/NCT03090048
NCT03090048Unknown早期 1 期

Treatment of Acne for Cases Resistant to Currently Available Measures Via Vitamin A With or Without Azithromycin in Topical Formulations

Manchanda Medical Clinic1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
入组人数
30
试验地点
1
主要终点
Measurement (dimensions) of acne lesions

研究概览

简要总结

Patients seen with acne lesions not having responded to existing treatments will be offered a placebo or a topical preparation consisting of Vitamin A USP with or without Azithromycin for a duration of 4-6 months USP for the objective of resolving the lesions without systemic side effects and via weekly follow-ups.

详细描述

The concentrations of the active ingredients is based on the enclosed articles and the formulations have been modified with an objective of minimizing the side effects.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
12 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with active lesions

排除标准

  • Patients on a treatment
  • Asymptomatic patients

研究组 & 干预措施

Vitamin A

Experimental

retinyl palmitate USP

干预措施: Vitamin A (Drug)

Azithromycin with Vitamin A

Experimental

USP grade ingredients

干预措施: Vitamin A (Drug)

Azithromycin with Vitamin A

Experimental

USP grade ingredients

干预措施: Azithromycin (Drug)

Azithromycin

Active Comparator

azithromycin monohydrate

干预措施: Azithromycin (Drug)

结局指标

主要结局

Measurement (dimensions) of acne lesions

时间窗: Every 4 weeks up to16 weeks

follow-up focussed on observation of changes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

DR. VINOD C TAWAR

Principal investigator

Manchanda Medical Clinic

研究点 (1)

Loading locations...

相似试验